                         SEQUENCE LISTING

<110>  Federal University of Rio Grande do Sul
       Universite Rennes 1
       CNRS
 
<120>  Peptides for preventing biofilm formation

<130>  BET 18P4296

<150>  EP19305205.7
<151>  2019-02-20

<160>  26    

<170>  PatentIn version 3.5

<210>  1
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P31

<400>  1

Arg Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Lys Gln Arg Val Gln Ser Glu Glu Gly Glu Asp Gln 
            20                  25                  30          


Ile Ser Gln Arg Glu 
        35          


<210>  2
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3

<400>  2

Arg Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Lys Gln 
            20          


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P1

<400>  3

Arg Val Gln Ser Glu Glu Gly Glu Asp Gln Ile Ser Gln Arg Glu 
1               5                   10                  15  


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P2

<400>  4

Arg Ala Glu Ala Phe Gln Thr Ala Gln Ala Leu Pro Gly Leu Cys Arg 
1               5                   10                  15      


Ile 
    


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3b

<400>  5

Leu Ser Ser Cys Gln Gln Tyr Leu Lys Gln 
1               5                   10  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3a

<400>  6

Arg Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Gln 
1               5                   10          


<210>  7
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3x

<400>  7

Arg Ser Cys Gln Gln Gln 
1               5       


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3y

<400>  8

Ile Gln Gln Ala Gln Gln Leu Ser 
1               5               


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3z

<400>  9

Ser Cys Gln Gln Tyr Leu Lys Gln 
1               5               


<210>  10
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<400>  10

Arg Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Xaa Gln Leu Ser Ser 
1               5                   10                  15      


Cys Gln Gln Tyr Leu Lys Gln 
            20              


<210>  11
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<400>  11

Xaa Arg Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Xaa Gln Leu Ser 
1               5                   10                  15      


Ser Cys Gln Gln Tyr Leu Lys Gln Xaa 
            20                  25  


<210>  12
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  misc_feature
<222>  (24)..(24)
<223>  Xaa can be any naturally occurring amino acid

<400>  12

Xaa Arg Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Gln Leu Ser Ser 
1               5                   10                  15      


Cys Gln Gln Tyr Leu Lys Gln Xaa 
            20                  


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<400>  13

Ile Gln Gln Ala Xaa Gln Gln Leu Ser 
1               5                   


<210>  14
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<400>  14

Xaa Ile Gln Gln Ala Xaa Gln Gln Leu Ser Xaa 
1               5                   10      


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is ornithine, N-lipid tail-glycine, N-neutral aromatic 
       moiety-glycine or N-acid aromatic moiety-glycine

<400>  15

Xaa Ile Gln Gln Ala Gln Gln Leu Ser Xaa 
1               5                   10  


<210>  16
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(3-guanidinopropyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is N-(sec-butyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is N-methylglycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is N-isobutylglycine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  X is N-isobutylglycine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is N-(4-aminobutyl)glycine

<400>  16

Xaa Ser Cys Gln Gln Gln Xaa Gln Gln Xaa Gln Gln Xaa Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Xaa Xaa Gln 
            20          


<210>  17
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(3-guanidinopropyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is N-(sec-butyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is N-isobutylglycine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is N-(4-aminobutyl)glycine

<400>  17

Xaa Ser Cys Gln Gln Gln Xaa Gln Gln Ala Gln Gln Xaa Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Xaa Gln 
            20          


<210>  18
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(3-guanidinopropyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is N-methylglycine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is N-(4-aminobutyl)glycine

<400>  18

Xaa Ser Cys Gln Gln Gln Ile Gln Gln Xaa Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Xaa Gln 
            20          


<210>  19
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(3-guanidinopropyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is N-(4-aminobutyl)glycine

<400>  19

Xaa Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Xaa Gln 
            20          


<210>  20
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(3-guanidinopropyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  X is N-isobutylglycine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is N-(4-aminobutyl)glycine

<400>  20

Xaa Ser Cys Gln Gln Gln Ile Gln Gln Ala Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Xaa Xaa Gln 
            20          


<210>  21
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(3-guanidinopropyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is N-methylglycine

<400>  21

Xaa Ser Cys Gln Gln Gln Ile Gln Gln Xaa Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Lys Gln 
            20          


<210>  22
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is N-methylglycine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  X is N-(4-aminobutyl)glycine

<400>  22

Arg Ser Cys Gln Gln Gln Ile Gln Gln Xaa Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Xaa Gln 
            20          


<210>  23
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is N-methylglycine

<400>  23

Arg Ser Cys Gln Gln Gln Ile Gln Gln Xaa Gln Gln Leu Ser Ser Cys 
1               5                   10                  15      


Gln Gln Tyr Leu Lys Gln 
            20          


<210>  24
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(sec-butyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is N-methylglycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is N-isobutylglycine

<400>  24

Xaa Gln Gln Xaa Gln Gln Xaa Ser 
1               5               


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N-(sec-butyl)glycine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is N-isobutylglycine

<400>  25

Xaa Gln Gln Ala Gln Gln Xaa Ser 
1               5               


<210>  26
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptidomimetic


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is N-methylglycine

<400>  26

Ile Gln Gln Xaa Gln Gln Leu Ser 
1               5               


